Yuji Aoki. “Comparison of Diuretic Effects Between Empagliflozin, a Sodium-Glucose Co-Transporter 2 Inhibitor With Osmotic Diuresis, and Tolvaptan, a Water Diuretic, in Two Type 2 Diabetic Patients Taking Sodium Diuretics”. Diabetes Research, vol. 2, no. 2, Oct. 2016, pp. 45-49, https://openventio.us/index.php/DR/article/view/1621.